New oral treatment for kidney cancer approved.
Traynor
Kate
K
D000284:Administration, Oral; D000818:Animals; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D017277:Drug Approval / Q000379:methods; D000068338:Everolimus; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D020123:Sirolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D000068338:Everolimus; D020123:Sirolimus